Ernexa Therapeutics Inc. Revenue From Contract With Customer Excluding Assessed Tax

Quick Answer

Ernexa Therapeutics Inc. reported Revenue From Contract With Customer Excluding Assessed Tax of $5.80 million for the year ending 2020.

  • Ernexa Therapeutics Inc. showed a decrease of -70.7% in Revenue From Contract With Customer Excluding Assessed Tax from 2019 to 2020.
  • This data is from Ernexa Therapeutics Inc.'s annual report (Form 10-K), filed with the SEC on March 11, 2021.
  • XBRL data for this metric is available from 2017 to 2020 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 4 years of available data (2017 to 2020), Ernexa Therapeutics Inc.'s Revenue From Contract With Customer Excluding Assessed Tax has declined by 72.7%.
  • Historical annual values: Fiscal year 2020: $5.80 million | Fiscal year 2019: $19.81 million | Fiscal year 2018: $23.34 million | Fiscal year 2017: $21.27 million.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: